Israel -
arabisk -
Ministry of Health
أكامولي للأطفال الكبار بطعم الفراولة
teva pharmaceutical indust.ltd - paracetamol 250 mg / 5 ml - syrup - paracetamol - analgesic, antipyretic.
Israel -
arabisk -
Ministry of Health
ميرتازاپين تيڤع ۳٠ ملغ
teva pharmaceutical indust.ltd - mirtazapine 30 mg - tablets - mirtazapine - episode of major depression.
Israel -
arabisk -
Ministry of Health
أهيستون أقراص
teva pharmaceutical indust.ltd - chlorpheniramine maleate 2 mg - tablets - substituted alkylamines - symptomatic relief of perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild uncomplicated urticaria and angioedema, amelioration of allergic reactions to blood or plasma, dermatographism, adjunctive therapy in anaplylactic reactions.
Israel -
arabisk -
Ministry of Health
نورميتن ٢٥
abic ltd. - atenolol 25 mg - tablets - beta blocking agents, selective - management of angina pectoris and hypertension, including hypertension of renal origin. late intervention after acute myocardial infarction.
Israel -
arabisk -
Ministry of Health
تريتايس ٢٫٥ ملغ
sanofi - aventis israel ltd - ramipril 2.5 mg - tablets - ace inhibitors, plain - hypertension congestive heart failure reduction of mortality in patients after mi with left ventricular dysfunction. for reducing the risk of myocardial infarction stoke cardiovascular death or need for revascularization procedures in patients over 55 years or more who have clinical evidence of cardiovascular disease (previous mi unstable angina or multivessel cabg or multivessel ptca) stroke or peripheral vascular disease. also for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in diabetic patients of 55 years or more who have one or more of the following clinical findings : hypertension (systolic blood pressure > 160 mmhg or diastolic pressure > 90 mmhg) high total cholesterol (>5.2 mmol/l) low hdl ( <0.9 mmol/l) current smoker known microalbuminuria clinical evidence of previous vascular disease. prevention of progressive renal failure in patients with persistent proteinuria in excess of 1g/day.